Impact of a preceding radiotherapy on the outcome of immune checkpoint inhibition in metastatic melanoma: A multicenter retrospective cohort study of the DeCOG

Sarah Knispel, Andreas Stang, Lisa Zimmer, Hildegard Lax, Ralf Gutzmer, Lucie Heinzerling, Carsten Weishaupt, Claudia Pföhler, Anja Gesierich, Rudolf Herbst, Katharina C. Kaehler, Benjamin Weide, Carola Berking, Carmen Loquai, Jochen Utikal, Patrick Terheyden, Martin Kaatz, Max Schlaak, Alexander Kreuter, Jens UlrichPeter Mohr, Edgar Dippel, Elisabeth Livingstone, Jürgen C. Becker, Michael Weichenthal, Eleftheria Chorti, Janine Gronewold, Dirk Schadendorf, Selma Ugurel^*

^*Corresponding author for this work

Clinic of Dermatology, Allergology and Venerology

University of Duisburg-Essen
Hannover Medical School
University of Erlangen–Nuremberg
University of Münster
Saarland University
University of Würzburg
HELIOS Klinikum Erfurt
University of Kiel
University of Tubingen
Ludwig-Maximilians-Universität
Johannes Gutenberg University Mainz
University of Mannheim
Wald-Klinikum Gera
University of Cologne
University Witten/Herdecke
Klinikum Quedlinburg
Elbe-Klinikum Buxtehude
Klinikum der Stadt Ludwigshafen

Impact of a preceding radiotherapy on the outcome of immune checkpoint inhibition in metastatic melanoma: A multicenter retrospective cohort study of the DeCOG

Fingerprint

Medicine and Dentistry

Immunology and Microbiology

INIS